Radiotherapy: Clinical Trials

3,011 trials of Radiotherapy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1373 completed, 432 unknown, 394 recruiting, 316 terminated. 1562 Phase 2, 639 Phase 1, 593 Phase 3, 303 Not applicable, 33 Early Phase 1.

By phase and status

PhaseTrialsStatus
Phase 21562Completed 701, Unknown 206, Recruiting 193, Terminated 186, Active not recruiting 124, Not yet recruiting 78, Withdrawn 67, Suspended 4, Enrolling by invitation 3
Phase 1639Completed 347, Terminated 93, Active not recruiting 56, Recruiting 46, Unknown 46, Withdrawn 35, Not yet recruiting 13, Enrolling by invitation 2, Suspended 1
Phase 3593Completed 284, Unknown 109, Recruiting 61, Terminated 52, Active not recruiting 49, Not yet recruiting 19, Withdrawn 15, Suspended 4
Not applicable303Completed 110, Recruiting 64, Unknown 61, Active not recruiting 27, Terminated 23, Not yet recruiting 9, Withdrawn 6, Enrolling by invitation 3
Early Phase 133Completed 12, Active not recruiting 7, Recruiting 6, Withdrawn 3, Terminated 2, Unknown 2, Not yet recruiting 1
Phase 424Unknown 10, Completed 9, Recruiting 2, Withdrawn 2, Not yet recruiting 1

Follow Radiotherapy: new trials by email Literature Review of Radiotherapy trials Research Report on Radiotherapy

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Adding Surgery and Radiation to the Usual Treatment for HER2-Positive Breast Cancer That Had Already Spread at Diagnosis
Biopsy Procedure, Biospecimen Collection, Breast Conservation Treatment - Anatomic Stage IV Breast Cancer AJCC v8, Metastatic HER2-Positive Breast Carcinoma
Phase 3RecruitingSWOG Cancer Research Network5622027-03-092026-10-13
MINTER Trial: Metal Intervention aNd ThErapy With Radiotherapy In Thoracic Cancer Using Copper Donor Therapy: A Phase 2, Open-Label Study
Disulfiram 250 mg, Copper Gluconate 2 mg, Radiation Therapy - Thoracic Cancer
Phase 2Not yet recruitingM.D. Anderson Cancer Center302027-03-012026-09-28
Assessment of Biosignature Classification of DCIS for RadioTherapy Benefit Post Lumpectomy (ABCD RT)
Radiation Therapy, Standard of Care Radiation Therapy, No Intervention - Breast Cancer
Phase 3Not yet recruitingNRG Oncology52702027-01-302026-09-30
Neoadjuvant Complete Response Customized Treatment Approach for Definitive Management of Breast Cancer
Neoadjuvant Chemotherapy, Radiation Therapy, MRI - Breast Cancer, HER2-positive Breast Cancer
Phase 1 / Phase 2Not yet recruitingOhio State University Comprehensive Cancer Center842027-01-152026-11-09
NG101m Adjuvant Therapy in Glioblastoma Patients
Intensity-modulated radiation therapy, Temozolomide, NG101m - Glioblastoma Multiforme
Phase 1 / Phase 2Not yet recruitingNeuGATE Theranostics522027-01-012025-10-21
LDRT Retreatment for Knee Osteoarthritis
Low Dose Radiation Therapy - Osteoarthitis, Osteoarthritic Knee Pain
Phase 2Not yet recruitingUniversity of Wisconsin, Madison1122027-01-012026-11-12
Glutaminase Inhibition and Chemoradiation in Advanced Cervical Cancer
Telaglenastat, Radiation treatment, Cisplatin - Advanced Cervical Carcinoma, Cervical Cancer
Phase 2Not yet recruitingWashington University School of Medicine422026-12-312026-09-03
Testing Repeat Radiation Therapy for Recurrent Non-small Cell Lung Cancer
Biospecimen Collection, Computed Tomography, Immunotherapy - Locally Recurrent Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8
Phase 2Not yet recruitingNRG Oncology1382026-12-182026-09-23
MRD-Adapted Low-Dose Radiation Therapy During Frontline Chemoimmunotherapy for Diffuse Large B-Cell Lymphoma
Low-Dose Radiation Therapy (LDRT), Standard Frontline Chemoimmunotherapy - Diffuse Large B-Cell Lymphoma
Phase 2Not yet recruitingUniversity of Nebraska502026-12-122026-11-06
Testing Safe Doses of Anti-Cancer Medicines, 5-Flurouracil (5-FU) and Tretinoin (ATRA), Added to the Usual Cancer Treatment of Ependymoma
Biospecimen Collection, Echocardiography Test, Fluorouracil - Childhood Posterior Fossa Ependymoma
Phase 1 / Phase 2Not yet recruitingChildren's Oncology Group702026-12-112026-09-30
Radiotherapy in Combination With Glofitamab in Relapsed/Refractory Diffuse Large B Cell Lymphoma
Glofitamab, Radiotherapy, Obinutuzumab - Relapsed /Refractory DLBCL
Phase 2Not yet recruitingOlivia Newton-John Cancer Research Institute402026-12-012026-06-08
PH Weighted Chemical Exchange Saturation Transfer MRI-Based Surgical Resection to Improve Survival in Patients With Glioblastoma
Chemical Exchange Saturation Transfer Magnetic Resonance Imaging, Contrast-enhanced Magnetic Resonance Imaging, Magnetic Resonance Imaging - Glioblastoma
Phase 3Not yet recruitingJonsson Comprehensive Cancer Center602026-12-012026-07-07
Sequential Chemotherapy Followed by Ultrahypofractionated Radiotherapy for Muscle-Invasive Bladder Cancer
Transurethral Resection of Bladder Tumor, Sequential Systemic Chemotherapy, radiotherapy - Bladder Cancer, TURBT
Phase 3Not yet recruitingAssiut University712026-12-012026-11-03
ctDNA-Guided CURB for OPD mNSCLC on TKI (CURB-TKI)
Radiotherapy - Metastatic NSCLC - Non-Small Cell Lung Cancer, OligoProgressive Metastatic Disease
Phase 2Not yet recruitingUniversity Health Network, Toronto602026-12-012026-11-04
Sintilimab Combined With LCCRT Followed by Capeox Chemotherapy in pMMR/MSS/MSI-L Locally Advanced Rectal Cancer
Oxaliplatin, Placebo, radiotherapy - Locally Advanced Rectal Cancer
Phase 3Not yet recruitingInnovent Biologics (Suzhou) Co. Ltd.5002026-11-252026-11-04
Becotatug Vedotin + Pucotenlimab+Platinum Induction and Sequential CCRT for Unresectable LA NSCLC
Becotatug Vedotin (MRG003)+pucotenlimab+platinum, radiotherapy - Non-Small Cell Carcinoma of Lung, Locally Advanced
Phase 2Not yet recruitingSun Yat-sen University242026-11-152026-10-20
Low-Dose Radiotherapy Plus Adebrelimab and Chemotherapy for Extensive-Stage Small Cell Lung Cancer
Adebrelimab + Chemotherapy + Radiotherapy - Small Cell Lung Cancer (SCLC), SCLC, Extensive Stage
Phase 2Not yet recruitingTianjin Medical University Cancer Institute and Hospital252026-11-152026-11-04
Traditional Chinese Medicine Preparation Alleviates Radiotherapy-induced Oral Mucositis in Head and Neck Cancer Patients.
Placebo oral liquid and mouthwash, Zishui Daohuo oral liquid combined with Kujiu mouthwash, Radiotherapy - Radiotherapy-induced Oral Mucositis
Phase 2RecruitingWest China Hospital1282026-11-052026-11-06
DEPART Study at Yale
Radiation Therapy - Dupuytren's Contracture
Phase 3Not yet recruitingYale University1582026-11-012026-10-13
Best Salvage Treatment for High-risk Relapsing Prostate Cancer (PEACE-9 - ESCALATE-RT)
Radiotherapy for MDT ± WPRT, Androgen Deprivation Therapy (ADT), Enzalutamide - Prostatic Neoplasms, Biochemical Recurrence
Phase 3Not yet recruitingEnte Ospedaliero Cantonale, Bellinzona1402026-11-012026-08-24

Showing 20 of 3011. Sign in to see all of them.

Conditions studied

Carcinoma, Non-Small-Cell Lung (262)  ·  Breast Neoplasms (219)  ·  Lung Neoplasms (209)  ·  Glioblastoma (205)  ·  Head and Neck Neoplasms (195)  ·  Prostatic Neoplasms (181)  ·  Squamous Cell Carcinoma of Head and Neck (175)  ·  Lymphoma (152)  ·  Rectal Neoplasms (142)  ·  Esophageal Neoplasms (126)  ·  Central Nervous System Neoplasms (122)  ·  Leukemia (111)  ·  Brain Neoplasms (107)  ·  Pancreatic Neoplasms (97)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (93)

Sponsors

National Cancer Institute (NCI) (120)  ·  M.D. Anderson Cancer Center (114)  ·  Radiation Therapy Oncology Group (81)  ·  European Organisation for Research and Treatment of Cancer - EORTC (68)  ·  Children's Oncology Group (63)  ·  Memorial Sloan Kettering Cancer Center (59)  ·  Alliance for Clinical Trials in Oncology (57)  ·  Sun Yat-sen University (49)  ·  Fudan University (43)  ·  SWOG Cancer Research Network (37)  ·  Mayo Clinic (29)  ·  Case Comprehensive Cancer Center (28)  ·  Northwestern University (27)  ·  Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (26)  ·  Dana-Farber Cancer Institute (25)

Countries

United States (1509)  ·  China (433)  ·  Canada (265)  ·  United Kingdom (203)  ·  France (194)  ·  Netherlands (146)  ·  Germany (139)  ·  Switzerland (134)  ·  Australia (126)  ·  Italy (125)  ·  Belgium (116)  ·  Spain (96)  ·  New Zealand (58)  ·  Puerto Rico (52)  ·  Sweden (50)

Top investigators

You Lu, MD (9)  ·  Arthur William Blackstock, MD (7)  ·  Amar Gajjar, MD (6)  ·  Corey J. Langer, MD (6)  ·  David H. Ilson, MD, PhD (6)  ·  Roger Stupp, MD (6)  ·  Edward G. Shaw, MD (5)  ·  Jane N. Winter, MD (5)  ·  John R. Yarnold, MD, FRCR (5)  ·  Peter W. Pisters, MD (5)  ·  Silvia Formenti, M.D. (5)  ·  Amol J. Ghia, MD (4)

Results publications

PMID 37505794, PMID 32827353, PMID 25057165, PMID 34780125, PMID 38603649, PMID 40135712, PMID 32691060, PMID 33242441, PMID 35135810, PMID 36346112, PMID 38320143, PMID 38421243, PMID 12126818, PMID 15172146, PMID 16467544, PMID 16971718, PMID 17008704, PMID 17236771, PMID 19269519, PMID 19901100, PMID 20138809, PMID 24121121, PMID 24423462, PMID 25023199, PMID 25366678, PMID 25592642, PMID 27243238, PMID 27465021, PMID 29926156, PMID 30207593, PMID 30523055, PMID 31416685, PMID 31500595, PMID 32499241, PMID 33496745, PMID 33539743, PMID 33607632, PMID 35115306, PMID 35157764, PMID 35731991, PMID 36596347, PMID 36603187, PMID 37890117, PMID 39121442, PMID 39863139, PMID 40073837, PMID 40967259, PMID 41531940, PMID 41544350, PMID 42085640

NIH funding

U10CA032102 (38), U10CA180886 (32), U10CA098543 (27), U10CA180868 (24), P30CA043703 (22), U10CA031946 (19), P30CA016672 (18), U10CA021115 (18), P30CA006973 (16), P30CA033572 (15), 2017 (12), P30CA138292 (12), 2023 (11), P30CA006927 (11), U01CA062475 (11)